Vycor Medical (VYCO) FCF Margin (2010 - 2026)

Vycor Medical (VYCO) has reported FCF Margin for 17 consecutive years, with 1.16% the latest figure, recorded in Q2 2026.

• On a quarterly basis, FCF Margin fell 1055.0% year-over-year to 1.16% in Q2 2026; TTM through Jun 2026 was 3.31%, a 376.0% increase from a year earlier, with the FY2025 full-year figure at 1.0%, down 445.0% from the prior year.
• FCF Margin was 1.16% for Q2 2026 at Vycor Medical, down from 21.68% in the prior quarter.
• Over five years, FCF Margin peaked at 21.68% in Q1 2026 and troughed at 25.1% in Q1 2022.
• A 5-year average of 1.73% and a median of 0.64% in 2023 frame the typical range for FCF Margin.
• Across the five-year window, FCF Margin slumped 2449 bps in 2022 and jumped 3192 bps in 2023, its largest moves.
• Over 5 years, FCF Margin stood at 12.18% in 2022, then jumped by 99 bps to 0.13% in 2023, then slumped by 6445 bps to 8.41% in 2024, then surged by 207 bps to 9.03% in 2025, then plunged by 113 bps to 1.16% in 2026.
• The last three FCF Margin figures came in at 1.16% (Q2 2026), 21.68% (Q1 2026), and 9.03% (Q4 2025), per Business Quant data.